CTRI/2023/04/051818尚未招募4 期
An Open-label, Prospective, Single-arm, Non-comparative, Multi-centric, Phase-IV Clinical Trial evaluating safety, tolerability and efficacy of Liothyronine 5 mcg & 20 mcg tablets in the management of thyroid deficiency.
Acme Generics Pvt. Ltd.0 个研究点目标入组 0 人开始时间: 待定最近更新:
试验速览
- 阶段
- 4 期
- 状态
- 尚未招募
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •Hypothyroid patients having persistent complaints, despite adequate treatment with L-T4 as evident from normalization of TSH, free T4 and T3 concentrations.
排除标准
- •1. pregnancy,
- •2. central hypothyroidism
研究者
相似试验
已完成
4 期
Assessment of efficacy and safety of Thyroxine Sodium in Indian Patients with Primary HypothyroidismCTRI/2019/03/018181Dr Faraz Farishta
招募中
4 期
A clinical study to evaluate the efficacy and safety of Levonorgestrel Intrauterine System (Emily) in Indian womenwith Dysfunctional Uterine BleedingCTRI/2012/07/002843HLL Lifecare Limited75
尚未招募
不适用
Safety and Efficacy of Dysmegesic in the management of Menstrual Pain in Female Subjects.CTRI/2021/01/030354Shield Healthcare Pvt Ltd
进行中（未招募）
1 期
A clinical trial to study the effects of selexipag on the heart in patients with Pulmonary Arterial HypertensioMedDRA version: 21.1Level: PTClassification code 10064911Term: Pulmonary arterial hypertensionSystem Organ Class: 10038738 - Respiratory, thoracic and mediastinal disordersPulmonary Arterial HypertensionEUCTR2019-004783-22-FRACTELION Pharmaceuticals Ltd.80
已完成
4 期
A Prospective, Multicenter, Single-Arm, Open-Label, Phase 4 Study of the Effects of Selexipag on Right Ventricular Remodeling in Pulmonary Arterial Hypertension Assessed by Cardiac Magnetic Resonance Imaging. (RESTORE)pulmonary arterial hypertensionPAHNL-OMON52455Actelion Pharmaceuticals5